The pharmaceutical giant’s jab was approved by European Union regulators in mid-March, following approval of vaccines made by Pfizer-BioNTech, Moderna and AstraZeneca. The 27-nation EU has signed a firm order for 200 million J&J doses and an option for 200 million more. As well as being the first that requires just a single injection rather than two, the Johnson & Johnson vaccine is easier to store. “With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens. Several European countries have enacted new restrictions to curb a surge of infections, as vaccination campaigns have been slower than in other countries such as the United States or Britain.

Source: The Local March 29, 2021 19:52 UTC